SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-064652
Filing Date
2023-05-25
Accepted
2023-05-25 16:31:03
Documents
13
Period of Report
2023-05-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2317030d1_8k.htm   iXBRL 8-K 25040
2 EXHIBIT 2.1 tm2317030d1_ex2-1.htm EX-2.1 31274
  Complete submission text file 0001104659-23-064652.txt   234572

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20230525.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20230525_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20230525_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2317030d1_8k_htm.xml XML 3451
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 23961219
SIC: 2834 Pharmaceutical Preparations